News • New presidency

Siemens Healthineers names Deepak Nath head of laboratory diagnostics

Siemens Healthineers has appointed Dr. Deepak Nath as President of Laboratory Diagnostics effective February 1.

Photo
Deepak Nath, the new head of laboratory diagnostics
Source: Siemens Healthineers

Nath succeeds Franz Walt, who served from 2014-2017, and led the business during its launch of the Atellica Solution. Nath will continue the endeavor to transform care delivery in the laboratory by growing the business, leveraging his extensive operational experience in healthcare. He will be based in Tarrytown, NY. “Siemens Healthineers seeks to benefit from market opportunities in the diagnostics market through the introduction of Atellica Solution,” said Michael Reitermann, Chief Operating Officer, Siemens Healthineers. “Deepak Nath’s exceptional leadership experience and deep industry knowledge will greatly benefit us as we look to expand the early success of Atellica Solution and drive wide adoption in the diagnostics market.”

Nath brings 20 years of wide-ranging leadership experience in healthcare to Siemens Healthineers, including general management, strategy, R&D, commercial operations and change management. For the past three years, Nath served as president of Abbott’s vascular division and as an executive officer of the company. His 10-year career there also comprised a variety of global leadership roles, including president of the molecular diagnostics division, divisional vice president and general manager of Ibis Biosciences, and several commercial leadership positions across mature and emerging markets. Earlier in his career he held positions at Amgen, where he lead process improvement initiatives; at McKinsey, serving a range of clients in the medical device and pharma industries; and as a scientist in the computational physics group at the Lawrence Livermore National Laboratory. Nath has B.S and M.S degrees in Mechanical Engineering and a Ph.D. in Theoretical Mechanics, all from the University of California, Berkeley.


Source: Siemens Healthineers

30.01.2018

Related articles

Photo

Sponsored • Earlier disease prediction and identification

The potential of AI in routine blood testing

It’s widely known that more than 70% of today’s medical decisions involve the results of laboratory tests, but the insights clinicians derive from these tests today may only be scratching the…

Photo

Sponsored • Siemens Naeotom Alpha

First CT scanner with photon-counting technology

Conventional CT imaging has reached its technical limitations: Resolution can only be improved by small margins and dose cannot be reduced significantly: Photon-counting technology enables drastic…

Photo

Sponsored • Photon-counting CT scanner

No detours, more detail

For the Siemens Healthineers team developing new and ever higher performing computed tomographs is daily fare. But when they introduced their most recent CT system an unusual sense of pride was…

Related products

Subscribe to Newsletter